Lin M - Search Results

1

Comparison of autogeneic and allogeneic natural killer cells immunotherapy on the clinical outcome of recurrent breast cancer.

Liang S, Xu K, Niu L, Wang X, Liang Y, Zhang M, Chen J, Lin M. Liang S, et al. Among authors: lin m. Onco Targets Ther. 2017 Aug 28;10:4273-4281. doi: 10.2147/OTT.S139986. eCollection 2017. Onco Targets Ther. 2017. PMID: 28894383 Free PMC article.

2

Safety and efficacy study of lung cancer stem cell vaccine.

Lin M, Li SY, Xu KC, Liu ZP, Mu F, Yuan YY, Wang XH, Chen JB, Li Q. Lin M, et al. Immunol Res. 2015 May;62(1):16-22. doi: 10.1007/s12026-015-8631-7. Immunol Res. 2015. PMID: 25743632

3

Safety and efficacy study of nasopharyngeal cancer stem cell vaccine.

Lin M, Yuan Y, Xu J, Cai X, Liu S, Niu L, Chen J, Li Q, Xu K. Lin M, et al. Immunol Lett. 2015 May;165(1):26-31. doi: 10.1016/j.imlet.2015.03.005. Epub 2015 Mar 18. Immunol Lett. 2015. PMID: 25796196

4

Prospective study of the safety and efficacy of a pancreatic cancer stem cell vaccine.

Lin M, Yuan YY, Liu SP, Shi JJ, Long XA, Niu LZ, Chen JB, Li Q, Xu KC. Lin M, et al. J Cancer Res Clin Oncol. 2015 Oct;141(10):1827-33. doi: 10.1007/s00432-015-1968-4. Epub 2015 Apr 10. J Cancer Res Clin Oncol. 2015. PMID: 25860618 Clinical Trial.

5

Circulating tumour cells as biomarkers for evaluating cryosurgery on unresectable hepatocellular carcinoma.

Shi J, Li Y, Liang S, Zeng J, Liu G, Mu F, Li H, Chen J, Lin M, Sheng S, Zhang H, Liu T, Niu L. Shi J, et al. Among authors: lin m. Oncol Rep. 2016 Oct;36(4):1845-51. doi: 10.3892/or.2016.5050. Epub 2016 Aug 25. Oncol Rep. 2016. PMID: 27573435

6

2003-2013, a valuable study: Autologous tumor lysate-pulsed dendritic cell immunotherapy with cytokine-induced killer cells improves survival in stage IV breast cancer.

Lin M, Liang S, Jiang F, Xu J, Zhu W, Qian W, Hu Y, Zhou Z, Chen J, Niu L, Xu K, Lv Y. Lin M, et al. Immunol Lett. 2017 Mar;183:37-43. doi: 10.1016/j.imlet.2017.01.014. Epub 2017 Jan 29. Immunol Lett. 2017. PMID: 28143792

7

Prospective study of percutaneous cryoablation combined with allogenic NK cell immunotherapy for advanced renal cell cancer.

Lin M, Xu K, Liang S, Wang X, Liang Y, Zhang M, Chen J, Niu L. Lin M, et al. Immunol Lett. 2017 Apr;184:98-104. doi: 10.1016/j.imlet.2017.03.004. Epub 2017 Mar 6. Immunol Lett. 2017. PMID: 28274792 Clinical Trial.

8

Short-term clinical efficacy of percutaneous irreversible electroporation combined with allogeneic natural killer cell for treating metastatic pancreatic cancer.

Lin M, Liang S, Wang X, Liang Y, Zhang M, Chen J, Niu L, Xu K. Lin M, et al. Immunol Lett. 2017 Jun;186:20-27. doi: 10.1016/j.imlet.2017.03.018. Epub 2017 Apr 6. Immunol Lett. 2017. PMID: 28392199 Clinical Trial.

9

Clinical efficacy of percutaneous cryoablation combined with allogenic NK cell immunotherapy for advanced non-small cell lung cancer.

Lin M, Liang SZ, Wang XH, Liang YQ, Zhang MJ, Niu LZ, Chen JB, Li HB, Xu KC. Lin M, et al. Immunol Res. 2017 Aug;65(4):880-887. doi: 10.1007/s12026-017-8927-x. Immunol Res. 2017. PMID: 28508945 Clinical Trial.

10

Percutaneous irreversible electroporation combined with allogeneic natural killer cell immunotherapy for patients with unresectable (stage III/IV) pancreatic cancer: a promising treatment.

Lin M, Liang S, Wang X, Liang Y, Zhang M, Chen J, Niu L, Xu K. Lin M, et al. J Cancer Res Clin Oncol. 2017 Dec;143(12):2607-2618. doi: 10.1007/s00432-017-2513-4. Epub 2017 Sep 4. J Cancer Res Clin Oncol. 2017. PMID: 28871458 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16,933 results

Search Page

Filters